On May 1, 2025 Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization (CRDMO) with a next generation RNA precision manufacturing platform, reported its participation in two premier industry events this May: the 3rd mRNA Process Development & Manufacturing Summit Europe in Berlin and the 2025 TIDES USA Conference in San Diego (Press release, Nutcracker Therapeutics, MAY 1, 2025, View Source [SID1234652469]). The company will also serve as an Official Expertise Partner for the Process Development & Manufacturing Summit Europe and an Associate Sponsor of TIDES USA.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
3rd mRNA Process Development & Manufacturing Summit Europe
Location: Hotel Palace Berlin, Berlin, Germany
Dates: May 6–8, 2025
Nutcracker Therapeutics’ Director of Biochip Research and Development, Babak Sanii, will present the company’s approach to rapid, personalized mRNA manufacturing using its proprietary NMU-Symphony platform. The talk will highlight how the company’s fully integrated, end-to-end microfluidic manufacturing process enables the production of personalized cancer therapies (PCTs) in as little as three weeks — from RNA design to patient-ready injectable vials. The use of single-use biochips ensures a closed, sterile system that eliminates the risk of patient-to-patient cross-contamination, supporting both scalability and safety in PCTs.
Presentation Title: End-to-End Microfluidic Manufacturing of Personalized Cancer Treatments
Presenter: Babak Sanii, director of biochip research and development
Date & Time: May 8, 2025, at 2:00 PM (local time)
Session: Scaling mRNA Manufacturing: Seamless Transitions from Lab to Market to Ensure Consistent Quality for Meeting Growing mRNA Vaccine & Therapeutic Demands
2025 TIDES USA
Location: Manchester Grand Hyatt San Diego, San Diego, CA
Dates: May 19–22, 2025
At TIDES USA, Colin McKinlay, senior director of chemistry and delivery technologies, will showcase Nutcracker Therapeutics’ suite of proprietary technologies, including BaseCracker for antigen construct design, CodonCracker for RNA sequence optimization, and its novel Nutshell delivery vehicles — all key elements in assembling PCTs. These tools are seamlessly integrated into NMU-Symphony, which enables fully enclosed synthesis of RNA drugs with quality, speed, and scalability.
Presentation Title: mRNA Manufacturing on the NMU-Symphony — A Rapid End-to-end Platform for the Design, Microfluidic Synthesis, and Delivery of Personalized Cancer Therapeutics
Presenter: Colin McKinlay, senior director, chemistry and delivery technologies
Date & Time: May 21, 2025, at 1:30 PM (local time)
For more information about these conferences, please visit the mRNA Process Development and Manufacturing Summit Europe and the TIDES USA websites. In addition, please visit Nutcracker Therapeutics’ CRDMO webpage for more information about its services.